Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study. [PDF]
Morikawa K +14 more
europepmc +1 more source
Idiopathic Pulmonary Fibrosis: Cellular Heterogeneity, Mechanisms, and Therapeutic Implications. [PDF]
Zuo L, Liu Q, Ye D, Fan J, Wu L.
europepmc +1 more source
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
J. Justice +10 more
semanticscholar +1 more source
Advances in the research and application of stem cell therapies for idiopathic pulmonary fibrosis. [PDF]
Xu L, Hou X, Zhou X, Jiang M.
europepmc +1 more source
P123 <break /> Mechanisms of treatment response to Pirfenidone of idiopathic pulmonary fibrosis (IPF) patients [PDF]
Michael T. Henry +7 more
openalex +1 more source
Jascayd (nerandomilast): a novel PDE4B inhibitor for idiopathic pulmonary fibrosis. [PDF]
Hujjat SFZ +4 more
europepmc +1 more source
Neurocognitive Impairment in Idiopathic Pulmonary Fibrosis: A Systematic Review of Current Evidence. [PDF]
Mihart D +5 more
europepmc +1 more source
The Role of Particle Inhalation in Idiopathic Pulmonary Fibrosis. [PDF]
Ghio AJ, Sangani RG, Todd NW.
europepmc +1 more source
The Role of Gut Microbiota on Idiopathic Pulmonary Fibrosis Mediated by Circulating Inflammatory Proteins: A Two‐Step, Two‐Sample Mendelian Randomization Study [PDF]
Hongyu Zhu +4 more
openalex +1 more source

